Nadia Permalloo

Nadia is Head of Screening Quality Assurance Development (Clinical) for the Screening Quality Assurance Service (National team)
Nadia Permalloo has worked in screening since 1998. She has worked in screening programmes at local, regional and national levels and is a registered nurse and midwife.

Nadia currently works nationally in quality assurance for the PHE Screening Quality Assurance Service. She cares that women and babies have high quality care and that we should be continually striving to improve what we do by supporting and developing staff delivering screening programmes.

Workshops have positive impact on antenatal screening data

Posted by: and , Posted on: - Categories: NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme
Attendees in discussion at tables at one of the workshops run by the national data team

The national antenatal screening team travelled across the country to deliver data workshops to give screening providers guidance on the submission of complete and accurate screening standards and key performance indicator data.

New quality assurance e-learning screening modules

Posted by: , Posted on: - Categories: NHS Abdominal Aortic Aneurysm Screening Programme, NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Newborn and Infant Physical Examination, NHS Newborn Blood Spot Screening Programme, NHS Newborn Hearing Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme, Screening Quality Assurance Service
One of the new e-learning slides

We've launched 3 e-learning modules aimed at our screening quality assurance service staff and the professional and clinical advisors who provide specialist expertise.

We’ve published first annual fetal anomaly screening data report

Posted by: and , Posted on: - Categories: NHS Fetal Anomaly Screening Programme
Screen showing the FASP laboratoty handbook. Specimen transport section has been highlighted in red.

We are pleased to publish the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP).

We have published the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP). It covers the period 1 April 2015 to 31 March 2016 and provides feedback on completeness of data submission and performance against the national standards.

Does age matter when thinking of NHS newborn screening programmes?

Posted by: , Posted on: - Categories: NHS Newborn and Infant Physical Examination, NHS Newborn Blood Spot Screening Programme, NHS Newborn Hearing Screening Programme

...to and including 3 months old. Infants older than 3 months and up to one year old. Children over one year old. Use this flow diagram to easily put children...

Getting out and about to make sense of antenatal screening data collection

Posted by: and , Posted on: - Categories: NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme

Our 3 antenatal screening programmes have joined forces with the national Screening Quality Assurance Service (SQAS) team to hold 8 regional workshops during 2017.